Welcome to our dedicated page for Enfusion news (Ticker: ENFN), a resource for investors and traders seeking the latest updates and insights on Enfusion stock.
Enfusion, Inc. (ENFN) appears in financial news as a provider of software-as-a-service solutions for investment managers, hedge funds, and asset managers, and as the subject of a completed acquisition by Clearwater Analytics Holdings, Inc. News coverage highlights Enfusion’s role in the investment management technology landscape and its integration into Clearwater’s broader platform.
Readers of this ENFN news page can expect articles that discuss Enfusion’s corporate transactions, including the definitive merger agreement announced with Clearwater and the subsequent completion of that acquisition in a transaction valued at approximately $1.5 billion. News items also describe the strategic rationale for combining Enfusion’s front-office capabilities with Clearwater’s middle- and back-office solutions to create a unified, cloud-native front-to-back investment management platform.
Historical news about Enfusion includes financial results such as fourth quarter and full year 2024 performance, where the company reported revenues, margins, and key metrics like Annual Recurring Revenue and Net Dollar Retention Rate. Such releases provide insight into Enfusion’s business model as a SaaS platform serving investment managers with platform subscriptions and managed services.
Other news references Enfusion’s positioning in the hedge fund and asset management sectors and its global footprint, as well as its description as an investment management SaaS platform that unites front-, middle-, and back-office teams. Following the acquisition, additional coverage focuses on how Enfusion’s technology is being used within Clearwater’s platform to support institutional investors.
Investors and researchers can use this ENFN news feed as an archive of transaction announcements, earnings-related disclosures, and strategic updates involving Enfusion, both as an independent public company and as part of Clearwater Analytics.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Enfusion, a leading provider of cloud-native software solutions for investment managers, is set to announce its first quarter 2023 financial results on May 9, 2023, before the U.S. markets open. A conference call is scheduled for 5:30 AM PT / 8:30 AM ET the same day to discuss the results with investors. Interested parties can access the call by dialing (833) 470-1428 and using conference ID 200171. A live webcast will also be available on Enfusion's Investor Relations page. The company boasts a robust investment management SaaS platform utilized by over 800 investment managers across 10 global offices.
Enfusion has partnered with Qontigo to enhance its risk management capabilities within its cloud-based investment management platform. This collaboration introduces Axioma Risk, an enterprise-level risk management solution that will provide comprehensive tools including exposure measurement, multi-factor risk models, and Value-At-Risk (VaR) analysis across various asset classes. The addition of Axioma Risk reflects Enfusion's commitment to continuous innovation and improvement of its services. CEO Oleg Movchan emphasized the importance of this partnership in enriching the investment management experience for clients. With this integration, Enfusion aims to assist fund managers in meeting increasing regulatory demands while optimizing risk management processes.